Whatever its strategy, the loss of Viagra’s patent protection will be very hard on Pfizer.

This article is exclusive to STAT+ subscribers

Pfizer did not immediately return requests for comment from CBS MoneyWatch. The company told the Financial Times that the list price for the majority of its medicines "remains unchanged," and those prices do not reflect what most patients or insurance companies ultimately pay for the drugs. The surging cost of drugs in the U.S. has spurred public anger and verbal barbs from the president, who before taking office accused the industry of "getting away with murder." Mr. Trump at the end of May announced a plan to lower drug prices, but the proposal did not include a timeline for implementation.

Drug Interactions

On May 30, he even declared that large drug companies would be announcing "voluntary massive drops in prices." Indeed, a recent survey found nearly half of diabetics are cutting back on treatment because of the skyrocketing price of insulin, with the American Medical Association last month calling it "shocking and unconscionable" that patients are struggling to afford such a basic drug. Pfizer was exposed last week after ignoring warnings from an Internet security company that spammers had compromised the pharma giant's computers. According to an online article published last week by popular technology magazine Wired, computers throughout Pfizer were infected with malware, a software program that allows a third party to capture passwords and user log-ins and to data mine private information. The unknown spammer was sending e-mails through Pfizer computers promoting, among other things, the sale of Viagra. Support Intelligence, a spam-infestation monitoring company, red-flagged Pfizer when spam blocks confirmed that the e-mails were coming from computers within the company.

What should I tell my healthcare provider before taking sildenafil?

"We approached Pfizer on multiple occasions to tell them about this issue," said Rick Wesson, CEO of Support Intelligence. "We did everything we could to help mitigate the problem, but for whatever reason internally, they didn't do it. Not even after repeated requests to fix it." On Aug. 24, Pfizer sent a memo to its employees admitting that a computer security breech has affected approximately 34,000 current employees, former employees, colleagues, and healthcare professionals. "This was done without Pfizer's knowledge or consent, in violation of Pfizer policy," the memo stated. When the company’s cholesterol treatment, Lipitor, lost its American patent in 2011 revenues declined by an eye-watering £4bn in a single year.

There are only two long-term responses to the challenge of losing patent protection. First, optimise the brand while you have a patent.

• Pfizer's Viagra has helped normalize conversations about male sexual health.
• The medication's popularity has contributed to advances in related medical fields.
• Sildenafil can also be used in the treatment of certain types of pulmonary hypertension.
• Pfizer's research helped establish the core mechanisms of erectile physiology.
• Viagra's effects are dose-dependent and should be carefully monitored.
• The medication is considered a first-line treatment for ED.
• Healthcare providers emphasize proper diagnosis before prescription.
• Viagra has special considerations for men with certain health issues.
• The drug's success has driven further innovation in sexual medicine research.

Unlike FMCG where brands often only reach their zenith 50 years after launch, big pharma marketers know they usually have only a 10-year window to make their profits and they act accordingly.

• Viagra was initially a surprise success after initial clinical trials.
• Pfizer's marketing included educational campaigns for healthcare professionals.
• The drug's availability increased global discussions on sexual wellness.
• Viagra is often mentioned in discussions about aging and vitality.
• Pfizer has continued to innovate within the sildenafil portfolio.
• The efficacy of Viagra can depend on individual health factors.
• Viagra's popularity has prompted discussions on sexual performance enhancement.
• Pfizer faced challenges in differentiating Viagra in competitive markets.
• The medication plays a significant role in sexual health treatment options.

Second, make sure your product pipeline is ready with the next big blockbuster. Once the profit potential of an off-patent brand like Viagra begins to diminish, there has to be a new brand with a protectable formula waiting to explode from your pipeline. The big question keeping Pfizer up at night is not what it will now do about Viagra, but what it has that can possibly replace it.

Popular FAQ

Last week we witnessed a major turning point in the history of modern pharmaceuticals: Viagra came off patent in the UK. For the past 15 years, the impotence drug has generated billions for its manufacturer Pfizer. In 1990, the company had been testing a new blood pressure drug called Sildenafil Citrate at its research facility in Kent. Although its effects on high blood pressure were disappointing, doctors involved in the patient trials reported a fascinating, if unexpected, side effect. Many of the test patients, who had previously struggled to achieve and maintain erections, were experiencing an unexpected revitalisation in the downstairs department.

What should I know about sildenafil before taking it?

Further tests confirmed the result and in 1998 Pfizer went to best viagra for men its naming bank, picked the name Viagra and launched the drug with a massive fanfare of publicity. Pfizer knew it had a wonder drug but also that without strong marketing its success would be severely limited by the social stigma of impotence. So Pfizer created a new condition – erectile dysfunction – to imply that the problem was not the man but the penis, and that the penis could be easily fixed by Viagra. Approximately 10 per cent of the male population suffer from some form of erectile dysfunction; around 750,000 British men took Viagra last year. And because Viagra does not cure the disorder but merely treats it, Viagra’s lifetime value is just as impressive as its potential penetration.

Who should not take sildenafil?

Add to that the unpalatable nature of the alternative treatments – either two vigorous hours with a vacuum pump before love making or multiple injections into the head of your penis – and it was clear that Viagra was a wonder drug. Within a year of Viagra’s successful launch Pfizer’s share price had doubled. Despite discovering the method for the mass production of penicillin, it was Viagra that made Pfizer’s corporate brand famous. But all good things come to an end. The European patent that has protected Viagra from copy-cat generic companies for more than a decade expired on Friday. BOSTON (Reuters) - Pfizer Inc said on Monday it won a patent infringement case against the U.S. unit of Teva Pharmaceutical Industries Ltd, preventing Teva from launching a generic version of Pfizer's erectile dysfunction drug Viagra until October 2019.

What happens if I miss a dose?

"The individual is no longer employed by the company." According to Wesson, Pfizer is just one of many Fortune 500 pharma companies plagued with this problem. His company outs many of them through its blog. "Organizations that are having these kinds of infections are having their intellectual properties exfiltrated to foreign countries," Wesson said. "That is the problem here, not that Viagra is being advocated from a compromised computer on Pfizer's network." Others, however, feel that Pfizer is not wholly at fault and that the story might have been sensationalized due to the fact that the spam in question was advertising Pfizer's erectile dysfunction drug. Viagra ads represented only a fraction of the spam sent through the security hole; other ads included those for penis enhancers and highly counterfeited drugs, such as Oxycontin.

Clinical Uses

"This type of problem could happen to any large company with a system like this," said Jay Bolling, president of Roska Healthcare Advertising. "I do think Pfizer is the victim in this case. But at the same time, the company should acknowledge the problem and rally the public around trying to offset this problem in the future. It should also educate the users of the system." Bolling recommends that companies follow basic Internet maintenance, such as system updates, virus-prevention updates, and log-file reviews, to isolate data that is vulnerable. "A group like Pfizer really has to weigh security access when it has thousands of representatives running around the system, downloading various files, and being able to access things on its servers," Bolling said.

Does sildenafil interact with other medicines (drug interactions)?

"When you have thousands of salespeople on the road with laptops connected to different systems on the company network, anything can happen." Sign in to ask about medicines, check stock and place orders. 📦 How many units of do you want? 50) $event.target.value = 50" placeholder="Enter quantity" class="w-full px-4 !py-3 border-2 border-blue-300 rounded form-control text-gray-900 font-semibold" /> Viagra 100mg is a trusted medication used to treat erectile dysfunction (ED). Each tablet contains 100mg of Sildenafil, a PDE5 inhibitor that enhances blood flow to the penis, helping to achieve and maintain an erection. Effective and fast-acting, Viagra 100mg provides reliable support for men's sexual health. A federal court judge ruled on Friday that the patent under dispute was valid and enforceable.

The decision, which affects about $1 billion in U.S. sales of Viagra, is subject to appeal.

Written By

It’s the kind of nightmare that would keep most marketers up all night. Imagine losing your ability to protect your product formula, brand equity, most of your key accounts and your pricing strategy overnight. That is what it means to lose patent protection. Viagra will still be marketed by Pfizer in the UK and across Europe. But it will now face competition from more than 20 different generic manufacturers which will flood the market with identical versions of Sildenafil Citrate.

Does Viagra affect sperm?

The extra competition combined with the lower research and development costs of these generic players means that, aside from suddenly facing multiple competitors, the average price for treatment will drop from around £10 per pill to less than £1 within weeks. Like all good big pharma organisations, Pfizer has been expecting and planning for the loss of patent protection for several years. It will attempt to keep Viagra in the market, albeit at a lower price, and encourage patients to continue to request the drug by name thus side-stepping the generic threat. For patients prescribed the drug via the NHS, however, one or more of the generics will replace Viagra on the government tender, saving the UK taxpayer millions of pounds but eliminating one of Viagra’s biggest sources of patients. Pfizer will almost certainly introduce its own generic version of Sildenafil Citrate, codenamed ‘White Diamond’, this week in an attempt to retain market share among the new generic options. The decision came as a surprise to analysts, most of whom had expected Viagra to lose market exclusivity in 2012.

• Viagra's quick onset makes it popular among users seeking spontaneity.
• The drug's contraindications include certain heart and eye conditions.
• Pfizer has developed generic versions when patents expired.
• Patients are advised to avoid high-fat meals to improve absorption.
• Viagra's use has expanded to include off-label pregnancy-related studies.
• The medication has been subject to numerous advertising campaigns.
• Pfizer invested in extensive post-marketing surveillance for Viagra.
• The safety profile of Viagra has been confirmed through long-term studies.
• Viagra influenced the rise of a broader market for sexual health drugs.

Pfizer's shares rose 2 percent to $18.23 in mid-morning trading on the New York Stock Exchange. The ruling comes as Pfizer braces for the loss later this year of market exclusivity for its biggest-selling product, the cholesterol-lowering drug Lipitor, which had 2010 sales of nearly $11 billion. "I think this is an important win for Pfizer," said Damien Conover, an analyst at Morningstar. "If you can hold on to $1 billion in sales of a high-margin product, that will definitely help offset the patent cliff Pfizer is facing."